Putting the award page together from the records…
Putting the award page together from the records…
Fresenius Kabi, LLC received this contract from Aspr/Orm-Sns, Office of Assistant Secretary for Preparedness and Response: $7.88M obligated so far for drugs and biologicals. It runs to 2027-07-29.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75A50326F80006, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75A50326F80006_7505_36F79725D0145_3600
Fresenius Kabi, LLC: all federal awards · Department of Health and Human Services: spending · Aspr/Orm-Sns: what it buys · The follow-on: recompete brief
ATROPINE 0.4MGML X 20ML SOLN. FOR INJ., MULTI-DOSE VIALS 8MG AND MIDAZOLAM SOLN. FOR INJ., 5MG/ML, MULTI-DOSE VIALS EO 14398
Up for re-bid: ends 2027-07-29. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
1 action since 2026-07-29. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-29 | 0 | $7.88M | ATROPINE 0.4MGML X 20ML SOLN. FOR INJ., MULTI-DOSE VIALS 8MG AND MIDAZOLAM SOLN. FOR INJ., 5MG/ML, MULTI-DOSE VIALS EO 14398 |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗